Cancer Patient-Specific Prognostic Information

نویسنده

  • Jay F. Piccirillo
چکیده

The goal of this project is to develop an interactive, Web-based Prognostigram program for adult patients with newly diagnosed cancer. The prognostic program creates individualized survival curves based on the Cox Proportional Hazards model of survival data from Barnes-Jewish Hospital (BJH) Oncology Data Services (ODS) and SEER*Stat (National Cancer Institute, Surveillance, Epidemiology, and End Results Software package). This program also includes important comorbid health information. Patient and physician focus groups were held to explore the utility of the program. Overall, both groups felt the program was informative and easy to use. Specific suggestions for improvement were made. Ultimately, the utility of the program needs to be assessed with Introduction Currently, prognostic estimates and decision-making in cancer care are primarily based on 5-year survival statistics published by the American Joint Committee on Cancer (1) and the American Cancer Society (2). These data relate mortality to site and TNM staging, but do not account for patient-specific factors such as patient age, gender, comorbidity, and cancer-related symptom severity. Since these factors are also independent predictors of survival (3-17), an index that considers these factors in addition to tumor site and TNM stage will be a better system for estimating survival. Information resources available to patients with newly diagnosed cancers are diverse. The physician and nursing staff serve as the primary providers of meaningful, appropriate information. Patients can supplement this information with general background information about cancer and cancer therapies from printed pamphlets, articles, and textbooks. Much of this didactic material is intended for non-medical audiences and is relatively easily understood. On the other hand, prognostic information, such as life survival or five-year survival rates, is more difficult for laymen to find and meaningfully interpret. At present, patients’ understanding of prognosis is generally limited to information provided to them by their physician. Physicians obtain prognostic information from the published literature and their personal experience with similarly affected patients. Interactive teaching and decision-making programs for patient use exist in varying medical specialties (18-20) One of the most successful programs is a videodisc series from the Foundation for Informed Medical Decision-Making (Hanover, NH). This series can help patients with back pain, breast cancer, ischemic heart disease, or benign prostatic hypertrophy understand their conditions and the various treatment options available to them. Other interactive teaching and decision-making resources for patients exist on the World Wide Web. For example, the American Heart Association "What’s My Risk" page (http://www.amhrt.org/risk/) uses baseline data from the Framingham study to determine the user’s ten-year risk of heart disease based on age, gender, race,

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Identification of Prognostic Genes in Her2-enriched Breast Cancer by Gene Co-Expression Net-work Analysis

Introduction: HER2-enriched subtype of breast cancer has a worse prognosis than luminal subtypes. Recently, the discovery of targeted therapies in other groups of breast cancer has increased patient survival. The aim of this study was to identify genes that affect the overall survival of this group of patients based on a systems biology approach. Methods: Gene expression data and clinical infor...

متن کامل

Human Cancer Modeling: Recapitulating Tumor Heterogeneity Towards Personalized Medicine

Despite diagnostic, preventive and therapeutic advances, growing incidence of cancer and high rate of mortality among patients affected by specific cancer types indicate current clinical measures are not ideally useful in eradicating cancer. Chemoresistance and subsequent disease relapse are believed to be mainly driven by the cell-molecular heterogeneity of human tumors that necessitates perso...

متن کامل

Human Cancer Modeling: Recapitulating Tumor Heterogeneity Towards Personalized Medicine

Despite diagnostic, preventive and therapeutic advances, growing incidence of cancer and high rate of mortality among patients affected by specific cancer types indicate current clinical measures are not ideally useful in eradicating cancer. Chemoresistance and subsequent disease relapse are believed to be mainly driven by the cell-molecular heterogeneity of human tumors that necessitates perso...

متن کامل

The Relationship Between Fibroblastic Growth Factor Receptor-1 (FGFR1) Gene Amplification in Triple Negative Breast Carcinomas and Clinicopathological Prognostic Factors

Background & Objective: In Triple-Negative Breast Cancers (TNBCs), estrogen receptor (ER), progesterone receptor (PR) and HER2/neu genes are not expressed. Fibroblastic Growth Factor Receptor-1 (FGFR1) gene product is a protein that acts as a receptor of thyrosin kinase. It plays a role in the proliferation, differentiation, and migration of malignant cells. The objective was t...

متن کامل

PRODUCTIO N OF PROSTATE-SPECIFIC ANTIGEN (PSA) BY A BREAST CANCER CELL LINE, SK-Br-3

PSA is a 33-KDa serine protease that is produced predominantly by prostate epithelium. However, it has been shown that about 30-40% of female breast tumors produce PSA and its production is associated with the presence of estrogen and progesterone receptors. We have now developed a new tissue culture system to study PSA production in breast cancer and its association with prognostic factors...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2002